Liver nodule ultrasound test for cancer patients
Part of Cancer, Digestive system clinical trials.
This study uses a special ultrasound with contrast dye to look at liver nodules seen on MRI in people who have had cancer. The goal is to see if the ultrasound can better tell if these nodules are cancerous.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must have had cancer before
- An MRI showed you have a liver nodule that is at least 1 cm (10 mm) across
- You are able to have an MRI and an ultrasound with contrast dye
- You have not had a large part of your liver removed or a liver transplant
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial compares two types of scans to see which detects liver cancer better in people at high risk. You would receive either an MRI with contrast or an ultrasound every 6 months to monitor for liver cancer.
This study tests a new, more detailed ultrasound technique to better see liver tumors. It may help doctors understand your tumor better without extra procedures.
This study tests a new ultrasound technique to catch liver cancer sooner. If you have regular imaging checks for liver cancer or are getting an MRI for a liver spot, you may be able to join.
This study compares a shorter, non-contrast MRI and ultrasound to monitor for liver cancer in people with cirrhosis whose ultrasound images aren’t clear enough. It aims to see which method works better and may help you get safer, more reliable follow-up.
This study compares MRI and ultrasound to see which is better at finding liver cancer early in people with liver cirrhosis. It also looks at body composition and other factors that could lead to worsening liver function.
This study uses a special ultrasound with contrast to help tell apart two conditions that cause high blood pressure in the liver: porto-sinusoidal vascular disorder (a rare disease of the liver's small blood vessels) and cirrhosis (scarring of the liver). The test may help avoid the need for a liver biopsy.
Hear when a new Hepatic Malignant Tumors trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.